Home CSA Medical

CSA Medical

RejuvenAir® System for COPD Patients with Chronic Bronchitis Earns CE Mark

The RejuvenAir System is a revolutionary cryosurgical device which applies Metered Cryospray ("MCS") of liquid nitrogen at -196◦C to targeted areas within the lungs through a minimally invasive bronchoscopic procedure. The extreme cold flash freezes damaged surface area lung cells which induces a rejuvenative healing process.

CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir System for COPD Patients with Chronic Bronchitis

4/3/19: CSA Medical plans to initiate the pivotal study designed as a prospective, multi-center, blinded randomized (2:1) sham controlled trial using the RejuvenAir System across 30 sites in the U.S., Europe and Canada with up to 330 subjects.